STOCK TITAN

Achieve Life Sciences: Logos reports 8.6% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Achieve Life Sciences, Inc. (ACHV) is the subject of an amended beneficial-ownership report in which Logos Global Management LP, its general partner Logos Global Management GP LLC, and control person William Arsani each report shared voting and dispositive power over 9,702,064 shares (8.6%). The reported securities comprise 5,951,032 common shares, options to acquire 1,000,000 shares and warrants to acquire 2,751,032 shares; the warrants are subject to a 9.99% beneficial ownership limitation.

Logos Global Master Fund LP and its general partner report 4,200,000 shares (3.8%), while Logos Opportunities Fund V LP and its general partner, along with control person Graham Walmsley, report 5,502,064 shares (4.9%). These are overlapping reports among the funds and related parties, not amounts to add together. The percentages use 110,034,457 common shares outstanding as of November 10, 2026. The reporting persons say they filed jointly but not as a group and disclaim beneficial ownership except to the extent of their pecuniary interests.

Beneficial ownership reported 9,702,064 shares (8.6%) Reported by Logos Global Management LP, Logos Global Management GP LLC and William Arsani; percentages use shares outstanding as of November 10, 2026.
Global Fund beneficial ownership 4,200,000 shares (3.8%) Reported by Logos Global Master Fund LP and its general partner.
Opportunities Fund V beneficial ownership 5,502,064 shares (4.9%) Reported by Logos Opportunities Fund V LP, its general partner and Graham Walmsley.
Common shares held 5,951,032 shares Component of the securities reported by Logos Global Management LP and related reporting persons.
Options to acquire 1,000,000 shares Included in the securities reported by Logos Global Management LP and related reporting persons.
Warrants to acquire 2,751,032 shares Subject to a 9.99% beneficial ownership limitation.
Common shares outstanding 110,034,457 shares As of November 10, 2026; used to calculate the reported ownership percentages.
beneficial ownership limitation regulatory
"warrants ... subject to a 9.99% beneficial ownership limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
shared voting power regulatory
"Shared voting power of 9,702,064"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power of 9,702,064"
pecuniary interest regulatory
"disclaims beneficial ownership except to the extent of that person's pecuniary interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much ACHV stock did Logos Global report beneficially owning?

Logos Global Management LP, its general partner and William Arsani each reported beneficial ownership of 9,702,064 shares, or 8.6%. The reported securities comprise 5,951,032 common shares, options to acquire 1,000,000 shares and warrants to acquire 2,751,032 shares.

What limit applies to the ACHV warrants in the ownership report?

The warrants to acquire 2,751,032 shares are subject to a 9.99% beneficial ownership limitation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





004468500

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The securities reported herein consist of 5,951,032 shares of Common Stock, standard options to acquire 1,000,000 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities reported herein consist of 5,951,032 shares of Common Stock, standard options to acquire 1,000,000 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities reported herein consist of 3,200,000 shares of Common Stock and standard options to acquire 1,000,000 shares of Common Stock. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities reported herein consist of 3,200,000 shares of Common Stock and standard options to acquire 1,000,000 shares of Common Stock. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities reported herein consist of 2,751,032 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities reported herein consist of 2,751,032 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities reported herein consist of 5,951,032 shares of Common Stock, standard options to acquire 1,000,000 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities reported herein consist of 2,751,032 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G



Logos Global Management LP
Signature:/s/ Arsani William
Name/Title:Managing Partner
Date:11/16/2026
Logos Global Management GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:11/16/2026
Logos Global Master Fund LP
Signature:/s/ Arsani William
Name/Title:Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP
Date:11/16/2026
Logos GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:11/16/2026
Logos Opportunities Fund V LP
Signature:/s/ Arsani William
Name/Title:Managing Member of Logos Opportunities V GP LLC, General Partner of Logos Opportunities Fund V LP
Date:11/16/2026
Logos Opportunities V GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:11/16/2026
Arsani William
Signature:/s/ Arsani William
Name/Title:Reporting person
Date:11/16/2026
Graham Walmsley
Signature:/s/ Graham Walmsley
Name/Title:Reporting person
Date:11/16/2026
Exhibit Information

Exhibit 99.1 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G

Keep reading